Clinical Trial Update: A SHR0302 BA Study on Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study of SHR0302 in healthy subjects has completed, with autoimmune diseases listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases

Drugs mentioned

• SHR0302 (SHR0302)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Autoimmune Diseases | Phase 1 | Status: COMPLETED